Future Cardia, a medical device company developing an implantable cardiac monitor intended to capture electrocardiogram (ECG) signals, and Artella Solutions Inc. (“ARTELLA”), a remote cardiac monitoring software and clinical services company, today announced an expanded strategic collaboration.
The companies began working together during Future Cardia’s pre-FDA phase by integrating ARTELLA’S Active State Monitoring platform with Future Cardia’s investigational implantable sensor to facilitate the secure transfer of ECG data for analysis.
“Future Cardia is bringing an implantable solution to a market that urgently needs innovation. ARTELLA and its holding company CorMedica Group were built to partner with technologies like this in which data, automation, clinical oversight, and Elite Customer Service can meaningfully change outcomes for patients and providers,” stated Sepand Moshiri, Artella Solutions Co-Founder and CEO.
Also Read: Kaneka Launches i-ED COIL™ in Europe
Through this collaboration, Future Cardia and Artella Solutions are evaluating the integration of ARTELLA’s remote cardiac monitoring platform into Future Cardia’s data and workflow ecosystem. ARTELLA’s device-agnostic patch and telemetry platform provides an opportunity to assess data transfer, interoperability, and workflow optimization. The partnership supports ongoing research and development efforts and reflects both organizations’ shared commitment to advancing connected cardiac monitoring technologies.
CEO of Future Cardia, Jae Bang, commented, “Future Cardia was founded on the belief that long-term physiologic data can enhance our understanding of cardiac health. Our collaboration with ARTELLA represents an important step in exploring how implantable and external monitoring technologies can work together to advance data integration and clinical workflow capabilities.”
SOURCE: Businesswire